Bernhard Wörmann

12.6k total citations · 2 hit papers
173 papers, 6.3k citations indexed

About

Bernhard Wörmann is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bernhard Wörmann has authored 173 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Hematology, 44 papers in Oncology and 41 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bernhard Wörmann's work include Acute Myeloid Leukemia Research (79 papers), Acute Lymphoblastic Leukemia research (29 papers) and Hematopoietic Stem Cell Transplantation (23 papers). Bernhard Wörmann is often cited by papers focused on Acute Myeloid Leukemia Research (79 papers), Acute Lymphoblastic Leukemia research (29 papers) and Hematopoietic Stem Cell Transplantation (23 papers). Bernhard Wörmann collaborates with scholars based in Germany, United States and Austria. Bernhard Wörmann's co-authors include Wolfgang Hiddemann, Thomas Büchner, Achim Heinecke, Claudia Schoch, Michael Unterhalt, Eva Hoster, Christa Fonatsch, Martin Dreyling, Wolfgang E. Berdel and Bernd Metzner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bernhard Wörmann

163 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

2007 621 citations Eva Hoster, Hermann Einsele et al. profile →
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

2022 110 citations Annika Fendler, Elisabeth G.E. de Vries et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Bernhard Wörmann

Since Specialization

Citations

This map shows the geographic impact of Bernhard Wörmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Wörmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Wörmann more than expected).

Fields of papers citing papers by Bernhard Wörmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Wörmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Wörmann. The network helps show where Bernhard Wörmann may publish in the future.

Co-authorship network of co-authors of Bernhard Wörmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Wörmann. A scholar is included among the top collaborators of Bernhard Wörmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Wörmann. Bernhard Wörmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy 2025 ·Journal of Market Access & Health Policy ·(unknown), (unknown), (unknown), Maureen Rutten‐van Mölken, (unknown), (unknown), Bernhard Wörmann, Daniel Widmer, P. Tilleul, Rubén Casado-Arroyo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stefano Capri, Carin A. Uyl‐de Groot, (unknown), Jörg Ruof	0
2	Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland 2023 ·Oncology Research and Treatment ·Axel Matzdorff, Sonja Alesci, Johanna Gebhart, Susanne Holzhauer, Marie Luise Hütter‐Krönke, Thomas Kühne, Oliver Meyer, Helmut Ostermann, Ingrid Pabinger, Mathias Rummel, Ulrich J. Sachs, (unknown), Karolin Trautmann‐Grill, Bernhard Wörmann	13
3	Ärztlich assistierte Selbsttötung 2023 ·GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) ·Jan Schildmann, Christian Junghanß, Michael Oldenburg, Ulrich S. Schuler, Bernhard Wörmann, Lorenz Trümper, Eva C. Winkler	1
4	Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie 2022 ·Oncology Research and Treatment ·Axel Matzdorff, Sonja Alesci, Johanna Gebhart, Susanne Holzhauer, Marie Luise Hütter‐Krönke, Thomas Kühne, Oliver Meyer, Helmut Ostermann, Ingrid Pabinger, Mathias Rummel, Ulrich J. Sachs, (unknown), Karolin Trautmann‐Grill, Bernhard Wörmann	0
5	COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety breakdown → 2022 ·Nature Reviews Clinical Oncology ·Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, John B.A.G. Haanen, Bernhard Wörmann, Samra Turajlic, Marie von Lilienfeld‐Toal	110
6	Onkologie und Ökonomie – wie frei sind wir wirklich in der Behandlung von Patientinnen? 2021 ·Oncology Research and Treatment* ·Bernhard Wörmann, (unknown), (unknown), Ingo Tamm, Andrew J. Ullmann, (unknown), Hermann Einsele, (unknown), (unknown)	1
7	Klinefelter-Syndrom und Krebs 2012 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·Sabine Kliesch, Stefan Heidemann, (unknown), Bernhard Wörmann	1
8	Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients 2012 ·Annals of Hematology ·(unknown), Annika Dufour, Friederike Schneider, Eva Hoster, Tobias Benthaus, Bianka Ksienzyk, Stephanie Schneider, Purvi M. Kakadia, Maria‐Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Jan Braess, Marion Subklewe, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann	27
9	Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome 2009 ·Journal of Clinical Oncology ·Annika Dufour, Friederike Schneider, Klaus H. Metzeler, Eva Hoster, Stephanie Schneider, Evelyn Zellmeier, Tobias Benthaus, Maria‐Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Jan Braess, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann	189
10	Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group 2008 ·Journal of Clinical Oncology ·Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach, Torsten Haferlach, Susanne Schnittger, Carsten Müller‐Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Peter Staib, Andreas Grüneisen, Wolfgang Kern, Albrecht Reichle, Georg Maschmeyer, Carlo Aul, Eva Lengfelder, Maria‐Cristina Sauerland, Achim Heinecke, Bernhard Wörmann, Wolfgang Hiddemann	232
11	Involved-Field Irradiation in Combination with Total-Body Irradiation (TBI) Does Not Increase Short-Term Toxicity Compared to TBI Alone in Patients with Advanced-Stage Low-Grade Non-Hodgkin Lymphoma 2002 ·Strahlentherapie und Onkologie ·(unknown), Heinz Schmidberger, Bernhard Wörmann, (unknown), Olivier Pradier, Clemens F. Hess	4
12	Leukaemia‐associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome 1999 ·British Journal of Haematology ·Frank Griesinger, (unknown), (unknown), Michael Falk, Anja Renziehausen, C. Troff, (unknown), Susanne Schnittger, Thomas Büchner, J. Ritter, Wolfgang Hiddemann, Bernhard Wörmann	49
13	Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome 1999 ·British Journal of Haematology ·Frank Griesinger, (unknown), (unknown), Michael Falk, Anja Renziehausen, C. Troff, (unknown), Susanne Schnittger, Thomas Büchner, J. Ritter, Wolfgang Hiddemann, Bernhard Wörmann	0
14	Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin 1999 ·European Journal of Cancer ·Gabriele Beyer-Sehlmeyer, Wolfgang Hiddemann, Bernhard Wörmann, J. Bertram	28
15	Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia 1998 ·Cancer ·Wolfgang Kern, Gerhard Behre, (unknown), Andrea Kerkhoff, (unknown), Hartmut Eimermacher, (unknown), Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann	13
16	Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities 1998 ·Leukemia Research ·Wolfgang Hiddemann, (unknown), Walter Verbeek, Bernhard Wörmann, Dagmar Haase, Claudia Schoch	7
17	Lectin‐induced increase in clonogenic growth of haematopoietic progenitor cells 1998 ·European Journal Of Haematology ·K. Vehmeyer, Tibor Hajtò, Katarina Hostanska, Stefan Könemann, (unknown), Reinhard Saller, Bernhard Wörmann	19
18	High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias 1997 ·Cancer ·Wolfgang Kern, Eberhard Schleyer, Michael Unterhalt, Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann	1
19	Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells 1996 ·Annals of Hematology ·Gerald Wulf, (unknown), Frank Strutz, (unknown), M. Hüfner, Christian Buske, Bernhard Wörmann, Wolfgang Hiddemann	27
20	Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia. 1994 ·PubMed ·Bernhard Wörmann, Christoph Reuter, M. Zühlsdorf, Th. Büchner, W. Hiddemann	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact